PROSPERiA SALUD
- Company typePrivate
- Founded2020
- HeadquartersAlvaro Obregón, Mexico
- Headcount11–50
- GTM typeB2B
- OfferingSoftware
PROSPERiA SALUD firmographics
Firmographics- Name
- PROSPERiA SALUD
- Legal name
- Prosperia Salud S.A. de C.V.
- Website
- https://prosperia.health
- Company type
- Private
- Founded year
- 2020
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Ownership category
- akta.pro rank
PROSPERiA SALUD industry classification
Industry- Product category
- Healthcare AI / Preventive Diagnostics Software
- SIC
- Services-Prepackaged Software (7372)
- akta.pro primary industry
- Visual Field & Functional Vision Testing (Perimetry, ERG/VEP, Contrast Sensitivity) (HLAHAJAC)
- akta.pro secondary industry
- eCOA/ePRO/eDiary & Patient-Facing Data Collection (HLACAOAB)
Keywords
Where PROSPERiA SALUD is headquartered
LocationHeadquarters
- HQ city
- Alvaro Obregón
- HQ country
- Mexico
- HQ region
- Latin America
Offices1 record
Markets served
PROSPERiA SALUD business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Marketing or Sales, Operations
Revenue model
- AI-Powered Screening Platform Subscriptions: PROSPERiA provides AI platforms for preventative healthcare enabling companies, clinics, pharmacies, and pharmaceutical companies to automate risk screening and deliver quality healthcare at scale. Revenue likely comes from platform subscriptions and per-evaluation fees.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Multi-year contract | Enterprise B2B pricing - quote-based |
Go-to-market motion1 record
Distribution channels1 record
Marketing channels3 records
PROSPERiA SALUD product offering
Product offeringCore offering
PROSPERiA SALUD develops AI-powered software platforms for preventive healthcare screening, including retinIA (computer-vision-based retinal image analysis for early detection of diabetic retinopathy, glaucoma, and macular edema) and evaliA (LLM-powered risk assessment engine for cardiometabolic, visual, and mental health risks). The platforms are designed for integration into occupational health campaigns, clinics, pharmacies, and corporate wellness programs, delivering automated screening results in under a minute without pupil dilation.
Product overview
PROSPERiA SALUD is a Mexican healthtech company that develops AI-powered platforms for preventative healthcare. The product ecosystem consists of two main solutions: retinIA (a computer vision-based platform for automated retinal image screening to detect diabetic retinopathy and other eye diseases) and evaliA (an LLM-powered risk assessment engine for evaluating cardiometabolic, mental health, and visual health risks). Both products are designed for integration into occupational health campaigns, clinics, pharmacies, and corporate wellness programs. The underlying technology includes ARIA (Automatic Retinal Image Analysis) which processes fundus photographs using AI algorithms.
Differentiator
Problem solved
Functional benefit
Brands
- retinIA: Automated screening platform for clinics and hospitals focused on eye health. Through automatic analysis of retinal images using AI, it allows early detection of abnormalities and provides personalized recommendations for patients and doctors in less than a minute without pupil dilation. Detects lesions associated with diabetic retinopathy, macular edema, suspected glaucoma, and other vision-threatening diseases.
- evaliA
Products and services
- retinIA An automated screening platform for clinics, hospitals, and health campaigns focused on eye health. Uses computer vision AI to analyze retinal fundus images for early detection of diabetic retinopathy, macular edema, suspected glaucoma, and other vision-threatening diseases. Provides results in under a minute without pupil dilation, intended for clinicians and enterprise occupational health programs.
- evaliA An intelligent risk assessment tool that uses LLM-powered chatbots and validated health questionnaires to identify predispositions to cardiovascular, metabolic, visual, and mental health conditions. Designed as a key tool for annual occupational health and safety campaigns in the workplace, intended for enterprise HR, wellness, and occupational health teams.
- ARIA (Automatic Retinal Image Analysis) Automatic retinal image analysis technology using medical AI algorithms that processes and interprets fundus photographs autonomously to identify microaneurysms, hemorrhages, and other early signs of retinal pathologies in seconds without human initial intervention.
Quantifiable outcome
- Employees with clear vision and comfortable eyes are up to 20% more efficient at digital tasks and have lower error rates
- +2 more outcomes
Companies that use PROSPERiA SALUD
Customer profileSegments4 records
Ideal customer profiles4 records
PROSPERiA SALUD technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration2 records
AI capability5 records
Feature6 records
PROSPERiA SALUD partnerships and signals
Strategic signalPartnerships
Three partnerships are on record, tiered minor and core.
- BayerminorBayer partnership for healthcare innovation, appearing in the company's recognition/partner logos section.
- RochecoreRoche-sponsored training program 'Curso de retinIA autónomo Roche' available through PROSPERiA's platform, suggesting a distribution/channel partnership for diabetic retinopathy screening solutions.
- MassChallenge MéxicominorAccelerator program partner; PROSPERiA was selected for the MassChallenge México 2020 accelerator program.
Scale indicators3 records
Recent moves6 records
Expansion highlights5 records
PROSPERiA SALUD competitors and assessment
Company assessmentDirect peers
- Eyenuk: US-based AI health company specializing in autonomous AI screening for diabetic retinopathy and other eye diseases using retinal fundus images. Highly comparable to PROSPERiA's retinIA platform in core clinical use case and computer-vision technology, though Eyenuk is more mature and US-anchored rather than Mexico/LatAm-focused.
- Digital Diagnostics (IDx-DR): Pioneer of FDA-cleared autonomous AI for diabetic retinopathy detection (IDx-DR). Direct overlap with PROSPERiA's retinIA in retinal AI screening for diabetic retinopathy, with Digital Diagnostics serving as the regulatory/clinical benchmark PROSPERiA would need to match for enterprise US/global hospital sales.
- Mediwhale: South Korean healthtech that uses retinal AI to predict systemic disease risk (cardiovascular, kidney, metabolic). Overlaps with PROSPERiA's combined retinIA + evaliA thesis of using eye imaging as a window into broader cardiometabolic risk, with a similar emerging-market-friendly positioning.
- Ada Health: Global AI symptom-assessment and risk-stratification platform. Directly comparable to PROSPERiA's evaliA in using AI-driven health risk assessment for early detection and triage, with a similar enterprise B2B GTM into insurers, employers, and health systems.
Broad incumbents
- Nanox AI (formerly Zebra Medical Vision): AI medical-imaging platform offering population-health insights across multiple imaging modalities (chest CT, mammography, bone health, etc.). Comparable to PROSPERiA's AI-imaging approach but broader and more US/global enterprise-focused rather than retinal-only or LatAm-focused.
- Roche Diagnostics (digital health initiatives): Global diagnostics and pharma major that runs the 'Curso de retinIA autónomo Roche' training program with PROSPERiA. Relevant as both a current channel partner and a broad incumbent whose broader digital-health strategy PROSPERiA is positioned within.
Regional players
- Doctoralia: Leading LatAm and European digital health platform owned by Docplanner, helping patients find and book healthcare professionals. Shares PROSPERiA's LatAm digital-health DNA and primary market (Mexico among others), though Doctoralia is a marketplace rather than an AI screening provider.
- Sophia (by Yana): Latin American mental-health and well-being chatbot platform. Adjacent overlap with evaliA's mental-health risk assessment module, with shared Spanish-language conversational AI approach for LatAm populations.
Emerging players
- K Health: AI-driven primary care and risk assessment platform serving consumers and enterprise payers in the US. Comparable to PROSPERiA's evaliA in predictive risk stratification for cardiometabolic and mental health conditions, though K Health is US-focused and at much later stage.
Others
- MassChallenge Mexico portfolio companies (peer cohort): PROSPERiA graduated from MassChallenge Mexico 2020. Comparable healthtech and AI peers from the same accelerator cohort (including various LatAm digital-health startups) provide ecosystem and stage-relevant comparables for similar GTM and capital trajectory.
Market position
Strengths4 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights6 records
Customer concentration
PROSPERiA SALUD social profiles
Digital presencePROSPERiA SALUD compliance and trust
Trust signalCompliance3 records
PROSPERiA SALUD financial estimates
Financial estimateRevenue estimate
Valuation estimate
PROSPERiA SALUD leadership team
Management profileNumber of profiles
Profiles2 records
PROSPERiA SALUD funding detail
Funding detailFunding overview
Funding rounds3 records
Investors4 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
PROSPERiA SALUD M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about PROSPERiA SALUD
What does PROSPERiA SALUD do?
PROSPERiA SALUD develops AI-powered software platforms for preventive healthcare screening, including retinIA (computer-vision-based retinal image analysis for early detection of diabetic retinopathy, glaucoma, and macular edema) and evaliA (LLM-powered risk assessment engine for cardiometabolic, visual, and mental health risks). The platforms are designed for integration into occupational health campaigns, clinics, pharmacies, and corporate wellness programs, delivering automated screening results in under a minute without pupil dilation.
Is PROSPERiA SALUD a public or private company?
PROSPERiA SALUD is a private company. It is classified as venture growth investor backed and is currently operating.
When was PROSPERiA SALUD founded?
PROSPERiA SALUD was founded in 2020. It employs 11 to 50 people.
Where is PROSPERiA SALUD based?
PROSPERiA SALUD is headquartered in Alvaro Obregón, Mexico, in the Latin America region.
How does PROSPERiA SALUD make money?
One revenue line is on record: AI-Powered Screening Platform Subscriptions.
Who are PROSPERiA SALUD's main competitors?
Direct peers on record are Eyenuk, Digital Diagnostics (IDx-DR), Mediwhale and Ada Health. Broad incumbents are Nanox AI (formerly Zebra Medical Vision) and Roche Diagnostics (digital health initiatives). Regional players are Doctoralia and Sophia (by Yana). K Health is listed as an emerging player. MassChallenge Mexico portfolio companies (peer cohort) is listed as an others.
Does PROSPERiA SALUD have an API?
No public API is recorded for PROSPERiA SALUD.
What industry is PROSPERiA SALUD in?
PROSPERiA SALUD's product category is Healthcare AI / Preventive Diagnostics Software. Its primary akta.pro industry code is HLAHAJAC, Visual Field & Functional Vision Testing (Perimetry, ERG/VEP, Contrast Sensitivity), with a secondary code of HLACAOAB, eCOA/ePRO/eDiary & Patient-Facing Data Collection. Its SIC code is 7372.